Breaking News in Spinal Cord Injury Research FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries

Xiao-Ming Xu

doi:10.3969/j.issn.1673-5374.2012.22.001

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Breaking News in Spinal Cord Injury Research FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries

DOI: 10.3969/j.issn.1673-5374.2012.22.001

Breaking News in Spinal Cord Injury Research FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries

Xiao-Ming Xu

Machine-generated Keywords：

Publication Date：2012-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 1685-1687 )

Neural Regeneration Research

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2012,7(22)